Millions of people worldwide suffer from hepatitis C virus (HCV). The classical treatment regimens used not so long ago using interferon and ribavirin a chance for healing or no more than 40% of patients
The emergence of new drugs Significantly better results was shown by new drugs, including the combination of sofosbuvir with daclatasvir, which can achieve treatment efficiencies in excess of 95%. But scientists are constantly on the lookout, trying to find even more effective drugs. Among these findings was ledipasvir, a substance that, in combination with sofosbuvir, allowed to achieve if not 100% healing, then very close to this figure. True, this is not possible for all HCV genotypes, but only for the first and fourth. As in most cases, the creator of the new drug was American Gilead Science. Moreover, since the substances sofosbuvir and ledipasvir must work in conjunction, Gilead immediately released the drug Harvoni, where both active substances were in one tablet or the following composition: Hepcinat LP 400 mg sofosbuvir; 90 mg or Ledipasvir
Generic Harvoni release
But the widespread use of Harvoni to get rid of HCV was prevented by the high cost of this effective drug. The release of Harvoni generics (analogues), for example, the drug Hepcinat LP, helped to somewhat improve the treatment situation. Its release under license and Gilead technology was established by the Indian pharmaceutical company Hetero Drugs, and the price of the generic was several tens of times lower than the original. And this is in full compliance with the budget original on the composition of active substances and the final pharmacological effect on patients. After entering the body, each of the active substances or the drug inhibits viral proteins. Sofosbuvir blocks the NS5B protein molecules responsible for the reproduction of the virus, and ledipasvir blocks the NS5A protein, which helps viruses invade healthy cells and spread throughout the body. As a result of the action of the drug, both the reproduction and the spread of the virus are suspended.
Indications for use
Yes, Hepcinat LP USE is a very effective medicine, but you should only buy it after passing a full examination and confirming the diagnosis. It is indicated for use in the case of hepatitis C genotypes 1 and 4. For treatment using Hepcinat LP, even patients with impaired renal and hepatic function are allowed. The medication is equally recommended to those who have already been managed to undergo therapy, only with a negative result, and, naturally, to those patients who are starting treatment for the first time. It is worth noting that most European countries have completely abandoned the use of interferon for the treatment of hepatitis C. The reason is the presence of strong side effects and low treatment effectiveness.
Where to buy Hepcinat LP in India
It is not possible to purchase the drug in official pharmacies due to the fact that under a licensing agreement, its export from India to European countries is prohibited. To buy Generic Harvoni Cost, just contact our online pharmacy. You can do this by using your phone or by contacting a consultant operator directly on the site. Your order will be delivered to the specified address without prepayment, payment for the goods is carried out after receiving and checking it for quality and originality of the package. Tablets are tasks once a day, washed down with water. The course of treatment can be 12 or 24 weeks. The treatment regimen and its duration are determined individually by the doctor. Moreover, it proceeds from the general condition of the patient, the genotype of the virus,